Empiriko teams up to scale liver-mimicking technology

Empiriko is working with CreaGen Biosciences to make its technology that mimics metabolism by liver enzymes more widely available to drug developers. The technology--called Biomimiks--was officially unveiled last month to help R&D teams quickly understand metabolic patterns, pathways and profiles of their drugs. Teaming with drug discovery service provider CreaGen is intended to help Empiriko scale and standardize the predictive technology. Release

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.